MUKKABSEMukka Proteins LtdMediumNeutral
Announced Fri, 15 May · 17:29 IST

Intimation of approval of issuance of Non-Convertible Debentures on a private placement basis.

Ncd High Yield 12pctFund Raising View source PDF

MUKKA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹23.85
prior close
₹23.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.9-3.7-3.6-4.0-3.6-5.4-5.0-5.6-2.7-3.4-8.7+3.1-0.7
Up moveDown movePending
AI summary

Mukka Proteins Ltd's Board has approved raising funds through two NCD issuances on private placement basis: Tranche 1 of up to Rs. 25 Crores at 12% coupon rate, and Tranche 2 of up to Rs. 50 Crores to be raised in multiple tranches. Total potential fund raise is up to Rs. 75 Crores. The debentures are secured, rated, listed, and redeemable with a tenure of 15 months. Both tranches will be listed on BSE's Wholesale Debt Market segment. The first tranche specifically carries a 12% per annum interest rate payable monthly.

Likely market impact

The high 12% coupon rate indicates expensive debt financing for the company, which could impact profitability. The debt raise provides liquidity but increases interest burden. Shareholders should monitor how these funds are deployed and the effect on financial ratios.